Witty Health Inc., an oncology-focused digital health company has
announced the release of Prescription Drug- Use Related Software (PDURS)
services on OncoPower,
an oncologist-designed platform that utilizes digital health and
professional networking to improve cancer care and precision medicine.
This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20190531005023/en/
The OncoPower’s Prescription Drug- Use Related Software (PDURS) suite
released today enables Prescription and Generic drug marketers to use
OncoPower to custom develop patient education, engagement, and
monitoring apps that are very specific to their prescription and generic
drugs. The suite is designed for branded and generic marketers to comply
with the PDURS
framework published by the Food and Drug Administration (FDA).
Witty Health OncoPower platform also includes Oncologist-to-Oncologist
consult suite and an Oncologist to Patient direct expert opinion suite
in a marketplace format. The Center for Medicare and Medicaid Services
(CMS) have regulations in place to reimburse payments for the treating
oncologists and consulting physicians. OncoPower Physician-2-Physician
consult suite facilitates these consultations efficiently and helps
generate documentation that complies with these rules.
“The current one-size-fits-all approach to monitoring cancer patients is
not improving engagement, adherence and outcomes as expected. We are
certainly in need of personalizing Apps to drugs and patient with
technologies like artificial intelligence, digital health, and
blockchain to improve outcomes and Quality of Life (QoL) particularly
for cancer patients” said Witty Health Co-Founder and Chief Oncologist,
Karthik Koduru, MD. “We are excited to release Prescription Drug- Use
Related Software (PDURS) suite. After pediatrics and pet care, oncology
is reported to be the third highest patient engaging indication. We
believe our highly drug-specific real-world data app that engages and
educates patients based on specific drug used at that moment will
further improve adherence and potentially outcomes.”
The current digital health tools are being offered using traditional
technologies. Witty Health is carefully researching and slowly
implementing blockchain capabilities into the platform. Once fully
built, OncoPower will be powered by a blockchain-integrated, digitally
generated security that will power the platform actions and serve as the
fuel of the incentivized oncology market.
“We are pleased to achieve these key milestones. In addition
to Prescription Drug- Use Related Software (PDURS), we are also
releasing an expert opinion product for patients to directly order an
oncologist consultation in a marketplace format. We believe this brings
more transparency to the healthcare industry,” stated Whitney Ahneman, a
Co-Founder and Chief Operating Officer of Witty Health.
About OncoPower
OncoPower (https://oncopower.org/)
is an oncologist-designed platform developed to create value for the
global cancer community. It is HIPAA-compliant and uses integrated an
clinical care and social determinants of health (SDoH) approach. It is
developed by Witty Health Inc, a Houston, TX based digital therapeutic
company that approaches complex problems with smart and inventive
solutions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190531005023/en/